118 related articles for article (PubMed ID: 30892689)
1. Lymphocytic colitis-like pattern of mucosal injury and the challenges in diagnosing cancer immunotherapy-related toxicity.
Grover S; Srivastava A
Cancer; 2019 Jun; 125(11):1768-1770. PubMed ID: 30892689
[No Abstract] [Full Text] [Related]
2. Pembrolizumab-Induced Microscopic Colitis.
Ahmed M; Francis G
Am J Gastroenterol; 2018 Apr; 113(4):629-630. PubMed ID: 29610496
[No Abstract] [Full Text] [Related]
3. Cytokine release syndrome as an important differential diagnosis of severe skin toxicity with organ damage during switch from immunotherapy to targeted therapy in metastatic melanoma.
Dimitriou F; Mangana J; Micaletto S; Braun RP; Dummer R
Melanoma Res; 2019 Feb; 29(1):107-108. PubMed ID: 30557221
[No Abstract] [Full Text] [Related]
4. Rare case of delayed onset colitis due to immunotherapy for malignant melanoma.
Sarofim M; Winn R
ANZ J Surg; 2019 Oct; 89(10):E472-E473. PubMed ID: 30136350
[No Abstract] [Full Text] [Related]
5. Discontinuation of melanoma combination immunotherapy.
Baker H
Lancet Oncol; 2017 Oct; 18(10):e565. PubMed ID: 28870612
[No Abstract] [Full Text] [Related]
6. Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis.
Lomax AJ; McGuire HM; McNeil C; Choi CJ; Hersey P; Karikios D; Shannon K; van Hal S; Carr U; Crotty A; Gupta SK; Hollingsworth J; Kim H; Fazekas de St Groth B; McGill N
Int J Rheum Dis; 2017 Sep; 20(9):1277-1285. PubMed ID: 28480561
[TBL] [Abstract][Full Text] [Related]
7. Opportunistic autoimmunity secondary to immunotherapy and melanoma: Back to ABCDE?
Kostine M; Stavris C; Chiche L
Eur J Cancer; 2017 Aug; 81():240-241. PubMed ID: 28434854
[No Abstract] [Full Text] [Related]
8. Development of Poliosis Following Checkpoint Inhibitor Treatment for Cutaneous Melanoma.
Ediriwickrema LS; Liu CY; Kikkawa DO; Korn BS
Ophthalmic Plast Reconstr Surg; 2019; 35(5):e121-e122. PubMed ID: 31373986
[TBL] [Abstract][Full Text] [Related]
9. A Life-Threatening Cause of Colitis.
Jaswani TS; Grider DJ; Bern MJ
Gastroenterology; 2018 Jan; 154(1):35-36. PubMed ID: 28918915
[No Abstract] [Full Text] [Related]
10. Immunotherapy toxicity predicted by circulating cytokines.
Gourd E
Lancet Oncol; 2018 Dec; 19(12):e676. PubMed ID: 30449658
[No Abstract] [Full Text] [Related]
11. Lymphocytic colitis secondary to ipilimumab treatment.
García-Varona A; Odze RD; Makrauer F
Inflamm Bowel Dis; 2013 Feb; 19(2):E15-6. PubMed ID: 22114048
[No Abstract] [Full Text] [Related]
12. Lymphocytic gastritis induced by pembrolizumab in a patient with metastatic melanoma.
Yip RHL; Lee LH; Schaeffer DF; Horst BA; Yang HM
Melanoma Res; 2018 Dec; 28(6):645-647. PubMed ID: 30256271
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune pancreatitis after nivolumab anti-programmed death receptor-1 treatment.
Dehghani L; Mikail N; Kramkimel N; Soyer P; Lebtahi R; Mallone R; Larger E
Eur J Cancer; 2018 Nov; 104():243-246. PubMed ID: 30454710
[No Abstract] [Full Text] [Related]
14. Mucosal Melanoma: a Literature Review.
Yde SS; Sjoegren P; Heje M; Stolle LB
Curr Oncol Rep; 2018 Mar; 20(3):28. PubMed ID: 29569184
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Eruption Secondary to Immunotherapy for Metastatic Melanoma Limited to Sites of Locoregional Melanoma Metastases: A Possible Variant of Locus Minoris Resistentiae.
Donaldson M; Owen JL; Choi JN
JAMA Dermatol; 2018 Jul; 154(7):846-847. PubMed ID: 29800007
[No Abstract] [Full Text] [Related]
16. Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulins.
Spänkuch I; Gassenmaier M; Tampouri I; Noor S; Forschner A; Garbe C; Amaral T
Eur J Cancer; 2017 Aug; 81():203-205. PubMed ID: 28641200
[No Abstract] [Full Text] [Related]
17. Histopathologic Features of Colitis Due to Immunotherapy With Anti-PD-1 Antibodies.
Chen JH; Pezhouh MK; Lauwers GY; Masia R
Am J Surg Pathol; 2017 May; 41(5):643-654. PubMed ID: 28296676
[TBL] [Abstract][Full Text] [Related]
18. Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome.
Mirza S; Hill E; Ludlow SP; Nanjappa S
Melanoma Res; 2017 Jun; 27(3):271-273. PubMed ID: 28146044
[TBL] [Abstract][Full Text] [Related]
19. Acute Lymphocytic Myocarditis With Anti-PD-1 Antibody Nivolumab.
Tadokoro T; Keshino E; Makiyama A; Sasaguri T; Ohshima K; Katano H; Mohri M
Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27650418
[No Abstract] [Full Text] [Related]
20. Pseudoprogression with subsequent complete response and severe thrombocytopenia to checkpoint inhibitor immunotherapy in a patient with advanced mucosal melanoma of the sinonasal cavity.
Philipp M; Frischhut N; Tschachler A; Steinkohl F; Weinlich G; Schmuth M; Nguyen VA
Anticancer Drugs; 2018 Oct; 29(9):914-918. PubMed ID: 29952773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
